Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Deerfield Beach, FL -- (SBWire) -- 05/01/2017 --Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

The report covers forecast and analysis for the metabolomics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the metabolomics market on a global level.

Request Sample Report: http://bit.ly/2bepfIs

In order to give the users of this report a comprehensive view on the metabolomics market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter's five forces model for the metabolomics market has also been included. The study encompasses a market attractiveness analysis, wherein technology segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the metabolomics market is segmented on basis of technology, indication, application and region. High performance liquid chromatography, mass spectrometry, capillary electrophoresis, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market. Applications include drug discovery, biomarker and nutrigenomics. Cardiology and oncology are the indication for metabolomics. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

Request For Free Pries Quotations http://bit.ly/2oWtbsU

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.

This report segments for metabolomics market as follows:

Metabolomics Market: Technology Segment Analysis

High performance liquid chromatography
Mass spectrometry
Capillary electrophoresis
Gas chromatography
Nuclear magnetic resonance spectroscopy

Metabolomics Market: Indication Segment Analysis

Cardiology
Oncology

Metabolomics Market: Application Segment Analysis

Drug discovery
Biomarker
Nutrigenomics

Metabolomics Market: Regional Segment Analysis

North America
US
Europe
Germany
France
UK
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa

Visit Our Blog : http://bit.ly/2pcNaAV